198 related articles for article (PubMed ID: 3672166)
1. [Blood products].
Benbunan M
Soins; 1987 Aug; (503):24-9. PubMed ID: 3672166
[No Abstract] [Full Text] [Related]
2. [Progress in treatment with blood and blood preparations with regard to achievements in blood preservation].
Nowicki P
Acta Haematol Pol; 1984; 15(3-4):213-21. PubMed ID: 6399433
[No Abstract] [Full Text] [Related]
3. The blood components--advancement in haemotherapy.
Nathan IV; Han P
J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928
[No Abstract] [Full Text] [Related]
4. [Indications for blood transfusion].
Khollan SR
Gematol Transfuziol; 1989 Aug; 34(8):47-53. PubMed ID: 2511059
[No Abstract] [Full Text] [Related]
5. Blood component therapy in the perinatal period: guidelines and recommendations.
DePalma L; Luban NL
Semin Perinatol; 1990 Oct; 14(5):403-15. PubMed ID: 2126893
[No Abstract] [Full Text] [Related]
6. [Special features of blood transfusions to hematologic patients].
Oksanen K
Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769
[No Abstract] [Full Text] [Related]
7. Guidelines for the administration of blood and blood products.
D'Aguillo A; Plafker J; Ehrenberg B; Gal K; Kim DU; Kuriyan M; Muschenheim F; Nayak S; Napolitano J; Pachter IB; Roddy FL; Wake E
J Med Soc N J; 1983 Jun; 80(6):437-43. PubMed ID: 6577194
[No Abstract] [Full Text] [Related]
8. Transfusion Management in Pediatric Oncology Patients.
Nellis ME; Goel R; Karam O
Hematol Oncol Clin North Am; 2019 Oct; 33(5):903-913. PubMed ID: 31466612
[TBL] [Abstract][Full Text] [Related]
9. [Blood transfusion and cancerology].
Bosset JF
Soins; 1981 May; 26(10):31-5. PubMed ID: 7020083
[No Abstract] [Full Text] [Related]
10. [Transfusion therapy in splenectomy in blood diseases].
Vorob'ev AI; Idel'son LI; Butrov AV; Gorodetskiĭ VM; Abashkin IuA
Vestn Khir Im I I Grek; 1982 Oct; 129(10):111-7. PubMed ID: 7179654
[No Abstract] [Full Text] [Related]
11. [Indications for transfusion].
Hollán Z
Orv Hetil; 1988 Feb; 129(6):271-6, 279. PubMed ID: 3347478
[No Abstract] [Full Text] [Related]
12. [Blood donation in a hospital for transfusion in hematological diseases].
Ikeda Y
Rinsho Byori; 1991 Mar; Suppl 88():243-7. PubMed ID: 1856975
[No Abstract] [Full Text] [Related]
13. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
Akush Ginekol (Sofiia); 1998; 37(4):46-9. PubMed ID: 10360055
[No Abstract] [Full Text] [Related]
14. [Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion].
Algora Weber M; Fernández Montoya A; Gómez Villagrán JL; Martín Vega C; Prats Arrojo I; Puig Alcaraz N; Pujol Bosch M; Vesga Carasa MA
Med Clin (Barc); 1999 Oct; 113(12):471-4. PubMed ID: 10570517
[No Abstract] [Full Text] [Related]
15. [The possibility of blood component therapy in Croatia (author's transl)].
Grgicević D; Bozović I; Pende B
Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696
[No Abstract] [Full Text] [Related]
16. [Indications for blood transfusion].
Hollán Z
Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636
[No Abstract] [Full Text] [Related]
17. [Granulocyte transfusion in hematological disorders methods and clinical effects (author's transl)].
Kurokawa I; Moriyama Y
Rinsho Ketsueki; 1977 May; 18(5):602-6. PubMed ID: 904081
[No Abstract] [Full Text] [Related]
18. [Replacing the administration of whole blood with blood derivatives].
Baklaja R
Bilt Hematol Transfuz; 1982; 10(2-3):115-29. PubMed ID: 6927292
[No Abstract] [Full Text] [Related]
19. [Cellular blood substitutes].
Z Gesamte Inn Med; 1979 Nov; 34(21):suppl 300-4. PubMed ID: 550615
[No Abstract] [Full Text] [Related]
20. [Targetted hemotherapy with special reference to the cellular components].
Dörner R
Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
